2 objectives understanding pain – acute vs chronic epidemiology risk: pain and death risk:...

80

Upload: jacob-may

Post on 18-Dec-2015

217 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations
Page 2: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

2

Objectives Understanding Pain – acute vs chronic

Epidemiology

Risk: pain and death

Risk: medication and death

Underwriter considerations

Questions

Page 3: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

What is pain?

3

Page 4: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

What is pain?

4

Page 5: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Complex pain pathways

5

Page 6: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Chronic pain Causal pain:

chest pain Cancer RSD

More generalized pain Fibromyalgia Chronic regional pain syndrome

Musculoskeletal pain Osteoarthritis Inflammatory arthritis

6

Page 7: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Chronic pain

7

Page 8: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Epidemiology of Chronic Pain

Common :20-30%+

Gender More women than men 55%/45%

Widespread by age Childhood Peak in the 60s for men, 80s for women

Long duration: 88% more than 2 years 46% more than 10 years

8

Page 9: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Understanding chronic pain

Chronic pain as a result/severity Cancer Cardiovascular Arthritis FMS

Chronic pain as comorbidity Obesity

Chronic Pain as inciting etiology (cause) Suicide Overdose

9

Page 10: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Chronic Pain as All Cause Mortality Indicator

10 years all cause mortality

UK- 5,800 people

Any chronic pain: HR 1.32

Severe chronic pain: HR 1.49

10

N Torrance et al, European J of Pain, 2009

Page 11: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Chronic pain and mortalitymeta analysischronic and widespread

11

Page 12: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Chronic pain – mortalitymeta analysis 10 studies Mild increase in mortality from cancer,

cardiovascular, fibromyalgia.

RR = 1.22

12

Page 13: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Chronic widespread pain HR 1.95

chronic pain, lifestyle factors, all cause mortality

13

Page 14: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Chronic widespread painHR 1.95

Mortality related to smoking and level of daily physical activity and Sleep disturbance

14

Page 15: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

15

Page 16: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Chronic widespread pain and mortality

sampling differences

16

Page 17: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

17

Page 18: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

5 year persistent pain Older population non cancer pain

Risk of death was lower in persons reporting moderate or greater pain than those with no or mild pain HR=0.85

Men with pain were not significantly more likely to die than men without pain to die HR=1.00

Women who reported non cancer pain as moderate or greater had lower mortality than women with less pain.

BUT, women with pain HR=0.40 had less risk of death than men without pain.

CONCLUSION: Older women with pain were less likely to die within 5 years than older women without pain, men in pain, or men without pain

18

Page 19: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Musculoskeletal Pain and Cancer Mortality

8 years average follow-up

United Kingdom- 4,500 people

Regional pain: HR 1.3

Widespread pain: HR 1.8

19

J McBeth et al, Rheumatology, 2009

Page 20: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Musculoskeletal Pain and Cardiovascular Mortality

8 years average follow-up

UK- 4,500 people

Regional pain: HR 1.1

Widespread pain: HR 1.3

20

J McBeth et al, Rheumatology, 2009

Page 21: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

New Musculoskeletal Pain and Mortality

1 and 10 years mortality

No pain in prior 2 years

UK- 48,000 people

21

KP Jordan et al, Brit J of Gen Practice, 2010

Page 22: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

New Musculoskeletal Pain and Mortality

1 year: Back SMR (age and sex) 2.07 Hip SMR 2.36 Shoulder SMR 1.42

10 year: Back SMR (age and sex) 1.17 Hip SMR 1.32

22

KP Jordan et al, Brit J of Gen Practice, 2010

Page 23: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

New Musculoskeletal Pain and Cancer

1 year (cancer free at baseline): Back SMR (age and sex) 1.79 Hip SIR 1.36 (not significant at 95%)

10 year (cancer free at baseline): Back SMR (age and sex) 1.25 Neck SMR 1.20 Hip SMR 1.15

23

KP Jordan et al, Brit J of Gen Practice, 2010

Page 24: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

What We Fear:

24

Page 25: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

US drug overdoses25 deaths/100,000

25

Page 26: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Top 3 Causes of Death 2005

15-24 25-34 35-44 45-54 55-64

Unint. injury

15,753

Unint. Injury

13,987

Unint. Injury 16,919

M. Neoplam 50,405

M. Neoplasm

99,240

Homicide 5,466

Suicide 4,990

M. Neoplasm 14,566

Heart Dis. 38,103

Heart Dis. 65,208

Suicide 4,212

Homicide 4,752

Heart Dis. 12,688

Unint. Injury

18,339

Chr Resp. 12,747

26

From 10 leading causes of death, CDC

Page 27: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Top 3 Causes of Death 2008

15-24 25-34 35-44 45-54 55-64

Unint. injury

14.089

Unint. Injury

14,588

Unint. Injury 16,065

M. Neoplam 50,403

M. Neoplasm 104,091

Homicide 5,275

Suicide 5,300

M. Neoplasm 12,699

Heart Dis. 37,982

Heart Dis. 66,711

Suicide 4,298

Homicide 4,610

Heart Dis. 11,336

Unint. Injury

20,354

Chr Resp. 14,042

27

From 10 leading causes of death, CDC

Page 28: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

The devil is in the Details: 15-24

2005 2008

Unint. MV 10,657

Unint. MV 8,647

Homicide 5,466

Homicide 5,275

Suicide 4,212

Suicide 4,298

Unint. Poisoning 2,484

Unint. Poisoning 3,188

M. Neoplasm 1,717

M. Neoplasm 1,663

Heat Dis.1,119

Heart Dis. 1,065

Unint. Drowning 649

Unint. Drowning 569 28

Page 29: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

25-342005 2008

Unint. MV 7,047

Unint. MV 6,358

Suicide 4,990

Unint. Poisoning 5,946

Homicide 4,752

Suicide 5,300

Unint. Poisoning 4,386

Homicide 4,610

M. Neoplasm 3,601

M. Neoplasm 3,521

Heat Dis.3,249

Heart Dis. 3,254

HIV1,318

HIV975

29

Page 30: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

35-442005 2008

M. Neoplasm14,566

M. Neoplasm12,699

Heart Dis. 12,688

Heart Dis.11,336

Unint. Poisoning6,729

Unint. poisoning7,545

Suicide6,550

Suicide6,703

Unint. MV6,491

Unint. MV5,446

HIV4,363

Homicide2,906

Homicide3,109

HIV2,838

30

Page 31: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

45-542005 2008

M. Neoplasm50,405

M. Neoplasm50,403

Heart Dis. 38,103

Heart Dis.37,892

Unint. Poisoning6,983

Unint. poisoning9,496

Liver Dis.7,517

Suicide8,287

Suicide6,991

Liver Dis.8,220

Cerebrovascular6,381

Cerebrovascular6,112

Unint. MV6,179

Unint. MV5,866 31

Page 32: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

55-642005 2008

M. Neoplasm99.240

M. Neoplasm104,091

Heart Dis. 65.208

Heart Dis.66,711

… …

Unint. Poisoning2,007

Unint. poisoning3,547

32

Unintentional Poisoning is not top 10

Page 33: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Painkiller nationpainkillers now kill more people than car crashes

33

Page 34: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Painkiller nation Drug overdose leading cause of injury death in 2012

117% increase from 1999 to 2012

41,502 overdose deaths in 2012 (16,007 analgesics)

33,175 deaths in 2012 unintentional

5465 – suicidal intent

80 – homicides

2782 – undetermined

2.5 million ER visits – drug misuse and abuse

34

Page 35: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Painkiller nationMore available drugs

+

More prescribers

=

More deaths

35

Page 36: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

More prescriptions

36

Page 37: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Too many prescriptions

37

Page 38: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Dose and Overdose

Opioid Dose HR Serious OD

None 0.19

1-19 mg/d 1.00 (ref)

20-49 mg/d 1.19

50-99 mg/d 3.31

100+mg/d 11.18

38

Serious events only, KM Dunn et al, Annals of Int Med 2010

Page 39: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Better (?) Drugs

39

IA Dhalla, CMAJ 2009

Page 40: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Abuse among Unintentional

Pharmaceutical Overdose Deaths

Age group % of OD Deaths % of Gen Population

Ratio

18-24 15.3%

25-34 23.4% 12.3% 190%

35-44 25.4% 13.3% 191%

45-54 27.7% 15.2% 182%

55+ 8.1% 28.5% 28%

40

Adapted from AJ Hall et al, JAMA 2008 (West Virginia 1999-2004)

Page 41: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Pain Clinics in Broward County FL

2007 : 4 clinics

41

Interim Report of the Broward Count Grand Jury, Spring 2009

Page 42: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Pain Clinics in Broward County FL

2007 : 4 clinics

2008: 47 clinics

42

Interim Report of the Broward Count Grand Jury, Spring 2009

Page 43: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Pain Clinics in Broward County FL

2007 : 4 clinics

2008: 47 clinics

2009: 115 clinics

During the first 6 months of 2008, the top 25 dispensing doctors of Oxycodone in the nation where in the state of Florida ,… 18 of the top 25 in Broward County”

43

Interim Report of the Broward Count Grand Jury, Spring 2009

Page 44: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Drug Overdose Deaths FL 2003

44

Death rates per 100,000 population

MMWR 60:26 July 8, 2011

Page 45: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Drug Overdose Deaths FL 2009

45

Death rates per 100,000 population

MMWR 60:26 July 8, 2011

Page 46: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Prescription Drug Overdose FL

46

Page 47: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Top Drugs Primary Cause of Deaths FL

2009 Oxycodone 1,185

Alprazolam 822

Methadone 720

Ethyl Alcohol 559

Cocaine 529

Hydrocodone 265

Diazepam 248

Cannabinoids 0

47

Page 48: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Top Drugs Most Common FL 2009

Ethyl Alcohol 4,046

Alprazolam (Xanax) 1,963

Oxycodone (OxyContin) 1,948

Cocaine 1,462

Methadone 985

Diazepam (Valium) 892

Hydrocodone 865

Cannabinoids 817

Heroin (only illicit opioid) 111

48

Page 49: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Top Drugs Most Lethal FL 2009

Heroin (only illicit opioid) 86%

Methadone 73%

Oxycodone 61%

Fentanyl (Durgesic, Actiq) 57%

Morphine 45%

Alprazolam 42%

Cocaine 36%

Diazepam 28%

49Fl Dept of Law Enforcement – Medical examiners commission 2010

Page 50: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Prescribing MD in Ontario 2006

50IA Dhalla, Can Fam Physician 2011

Page 51: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

More Usage: Oxycodone 2009

51

Rank Country Relative Consumption

per Capita

1 United States of America 33.6

2 Canada 24.2

3 Australia 11.8

4 Denmark 11.2

5 United Kingdom 6.7

10 Germany 4.3

15 Israel 2.3

20 Austria 1.0

http://www.painpolicy.wisc.edu/internat/opioid_data.htmlAnother neat website: http://ppsg-production.heroku.com/chart

Page 52: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Abuse among Unintentional

Pharmaceutical Overdose Deaths

52

AJ Hall et al, JAMA 2008 (West Virginia 1999-2004)

Page 53: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Overdose and Prescribed Opioids

Men 123 Women 112

Age 18-44 119 45-64 92 65+ 151

Hx of depression: Yes 239 No 77

Hx of subst. abuse: Yes 274 No 107

53

Serious events only, unit is per 100,000 Person Years, KM Dunn et al, Annals of Int Med 2010

Page 54: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

CDC - Risk factors

54

Page 55: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

And Do Opioid Work for Non-Cancer Chronic Pain?

“Critical research gaps on use of opioids for chronic non-cancer pain include: lack of effectiveness studies on long term benefits and harms of opioids…”(1)

55

(1) R Chou et al, Research Gaps on Use of Opioids for Chronic Noncancer Pain…, J of Pain, 2009

Page 56: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Opioid Use: Screening Tools

“There was not a single screening tool that can be applied universally to all patients who are on opioid therapy for chronic non-cancer pain”(1)

56

(1) DR Solanki et al, Pain Physician 2011

Page 57: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Treating Chronic Pain: a Balancing Act

57

Page 58: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

GO Localized

Recent

No depression

No recreational drugs

Good function

Good support

Low doses

One MD

58

Page 59: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Caution Morphine

Xanax

Alcohol

Past recreational drugs

Depression

No evidence of non-drug pain management

Low doses

Multiple MDs

59

Page 60: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

STOP

Polypharmacy

Increasing dosage

Disability

Depression

60

Page 61: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Ratings

61

MILDMILD•Mild impairmentMild impairment

•Stable medsStable meds•No depressionNo depression•Narcotics for Narcotics for

flare-upsflare-ups

Page 62: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Ratings

62

MILDMILD•Mild impairmentMild impairment

•Stable medsStable meds•No depressionNo depression•Narcotics for Narcotics for

flare-upsflare-ups

MODERATEMODERATE•Localized painLocalized pain

•ActiveActive•ADL OkADL Ok

•Good social Good social networknetwork

Page 63: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Ratings

63

MILDMILD•Mild impairmentMild impairment

•Stable medsStable meds•No depressionNo depression•Narcotics for Narcotics for

flare-upsflare-ups

MODERATEMODERATE•Localized painLocalized pain

•ActiveActive•ADL OkADL Ok

•Good social Good social networknetwork

SEVERESEVERECombo of:Combo of:•DisabilityDisability

•ImpairmentImpairment•Multiple medsMultiple meds

•Increasing Increasing dosagedosage

•Depression Depression

Page 64: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Chronic pain ratings

Page 65: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Chronic pain ratings

65

Page 66: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

RATINGS

Page 67: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Case 1 MR. Max Pain is a 54 yo male who injured his lower back a

few months ago while golfing

Imaging by MRI etc ruled out maliganancy, arthritis, disc disease, or spinal stenosis.

He was prescribed PT, analgesics, and told to top golf for a few months.

He is an VP of multibillion dollar corp based in Dallas TX

History of anxiety and poor sleep in past, currently on no medication for either.

Admits to one martini nightly, never hx of ETOH abuse in past

67

Page 68: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Case 1 Married, two successful children, and 2 grandchildren.

Attends church every Sunday, and does volunteer work with his wife of 25 years when time allows.

He returns to his PCP after 6 months with no relief. Pain is 4/10 on good days and 7/10 on bad days usually worse at the end of the day

PCP prescribes Tramadol and Hydrocodone for use on the when pain is at its worst.

He tries acupuncture in addition.

Also, the CLBP has caused some sleep disruption and he asks his PCP for a sleeping pill.

68

Page 69: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Case 1 He returns to his PCP 3 and six months later and

reports improvement, but still uses opoid and sleeping pill PRN.

Questions at this point? Function – golf etc Stability of dose of percoset Any depression? Alcohol Side effects

69

Page 70: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Case 2 MR. Max Pain is a 54 yo male who injured his lower

back a few months ago while golfing

Imaging by MRI etc ruled out malignancy, arthritis, disc disease, or spinal stenosis.

He is an VP of multibillion dollar corp based in Dallas TX

History of anxiety and poor sleep in past and was treated with Paxil.

Admits to two martini nightly, 2 -3 nightly on weekends

70

Page 71: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Case 2 Divorced with two children, one a successful attorney

the other a successful doctor who has been in and out of rehab several times for substance abuse. His son the doctor and the divorce have been difficult for him

He works 15 hour days, no exercise, eats mostly in restaurants, his BMI is 34.

He currently self medicates with GABA and melatonin 6 mg nightly to help sleep. He has been prescribed Xanax for occasional use and has to take about 5 xanax 0.75 mg a month to sleep. He tries to keep the xanax use to a minimum.

71

Page 72: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Case 2 His PCP prescribes COX2 inhibitor Tramadol and PT.

He is told he needs to stop golf for several months, lose 50 pounds and control stress.

He LOVES golf

He returns to his PCP after 6 months with mild improvement, but the pain has disrupted his sleep and he is taking more xanax for sleep and anxiety.

He has lost 20 pounds, still can’t play golf and is feeling a a little depressed about it. Otherwise he is fully funcitonal and still goes to the office 15 hours a day

72

Page 73: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Case 2 His PCP offers encouragement and positive

reinforcement about the weight loss and renews his xanax, COX2 inhibitor and Tramadol. f/u six months

?

73

Page 74: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Case 3 MR. Max Pain is a 54 yo male who injured his lower back a

few months ago while golfing

Imaging by MRI etc ruled out maliganancy, arthritis, disc disease, or spinal stenosis.

He was prescribed PT, analgesics, and told to top golf for a few months.

He is an VP of multibillion dollar corp based in Dallas TX

History of anxiety, depression and poor sleep in past, currently on no prescription medication.

Admits to one martini nightly, never hx of ETOH abuse in past

74

Page 75: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Case 3 Divorced with two children, one a successful attorney

the other a successful doctor who has been in and out of rehab several times for substance abuse. His son the doctor and the divorce have been difficult for him

He works 15 hour days, no exercise, eats mostly in restaurants, his BMI is 34.

He currently is self medicates with melatonin 6 mg nightly to help sleep. He has been prescribed Xanax for occasional use and has to take about 5 xanax 0.75 mg a month to sleep. He tries to keep the xanax use to a minimum.

75

Page 76: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Case 3 His PCP prescribes COX2 inhibitor Tramadol, percocet and PT.

He is told he needs to stop golf for several months, lose 50 pounds and control stress.

He LOVES golf

He returns to his PCP after 6 months with mild improvement, but the pain has disrupted his sleep and he is taking more xanax for sleep and anxiety.

He has lost 5 pounds, still can’t play golf and is feeling a a little depressed about it. Otherwise he is functional but has cut his work schedule at the office 7 hours a day due to fatigue

76

Page 77: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Case 3 His PCP offers encouragement and positive

reinforcement about the weight loss and renews and increases his xanax dose, COX2 inhibitor and Tramadol, percocet and prescribes a SSRI for depression.

?

77

Page 78: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Case 4 34 yo female with a history of rheumatoid arthritis and FMS

RA,, onset 4 years ago in remission with MTX and NSAID for 2 years.

RA limited to small joints of the hands.

Minimal morning stiffness of joints.

FMS is treated with Lyrica for 7 years.

She c/o fatigue, poor sleep, and lack of motivation

Works parttime as – phone marketing from home

?

78

Page 79: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

Questions?

79

Page 80: 2 Objectives  Understanding Pain – acute vs chronic  Epidemiology  Risk: pain and death  Risk: medication and death  Underwriter considerations

80

® Trademark of Optimum Group inc.